STLN
Starling Oncology, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$6.59
−0.90%Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.08
- EPS estimate
- -$0.06
- Revenue actual
- $161.3M
- Revenue estimate
- $155.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -25.0%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.06 | -$0.08 | Miss -25.00% | $161.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 6, 2026